More relief for Dupixent as FDA pushes back Lilly, Pfizer eczema decisions on safety concernsby NileApril 7, 2021 More relief for Dupixent as FDA pushes back Lilly, Pfizer eczema decisions on safety concerns aliu Wed, 04/07/2021 – 10:03